m+Medelevator.RU
← Поиск публикаций
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2025

Plasticizer mixture exposure-induced preeclampsia pathogenesis: Integrated single-cell and bulk transcriptomics, network toxicology, and molecular docking insights.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zu Chenwan, Li Min, Ren Sen, Chen Niuniu, Ye Lan, Guo Rui

Аннотация

PURPOSE: While plasticizers are known preeclampsia (PE) risk factors, the mechanisms of combined exposure to ATBC, DEP, DMP, and DOP remain unclear. This study aims to elucidate their biological targets and pathogenic mechanisms in PE.

METHODS: PE/toxin gene targets were predicted from databases. Biomarkers were identified via differential expression analysis, machine learning, expression verification, and ROC analysis. GSEA, immune infiltration analysis, molecular dynamics simulation, and scRNA-seq elucidated mechanisms and cell subsets. RT-qPCR and IHC validated target expression.

PRINCIPAL RESULTS: We identitified three key targets (BCL6, FLT1, and INHA) enriched in the ribosome pathway and correlated with activated dendritic cells (p < 0.01). Compared with other targets, FLT1 exhibited the lowest binding energies with DEP, DMP, and DOP, all of which were ≤5.8 kcal/mol. The scRNA-seq analysis identified villous cytotrophoblast (VCT) as a key cell type with dynamic expression of BCL6 and FLT1 during differentiation. RT-qPCR and IHC confirmed the upregulation of BCL6, FLT1, and INHA in PE placental tissues, and their differential expression in VCT cells between the control and experimental groups.

MAJOR CONCLUSION: The findings clarify plasticizer toxicity and provide novel insights into PE pathogenesis, offering a theoretical basis for improved clinical treatments.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты